Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/12/2024 | $15.83 | Buy → Hold | Kepler |
10/7/2024 | $30.00 | Neutral → Buy | BTIG Research |
3/21/2024 | $22.00 → $30.00 | Hold → Buy | Jefferies |
1/9/2024 | $17.00 → $26.00 | Hold → Buy | Deutsche Bank |
8/25/2023 | $17.00 | Buy → Hold | Deutsche Bank |
8/15/2023 | $20.00 | Neutral | JP Morgan |
6/30/2023 | $19.00 → $17.00 | Hold → Buy | Deutsche Bank |
5/8/2023 | $17.00 | Buy → Hold | Jefferies |
Kepler downgraded Frontline from Buy to Hold and set a new price target of $15.83
BTIG Research upgraded Frontline from Neutral to Buy and set a new price target of $30.00
Jefferies upgraded Frontline from Hold to Buy and set a new price target of $30.00 from $22.00 previously
6-K - Frontline plc (0000913290) (Filer)
6-K - Frontline plc (0000913290) (Filer)
20-F - Frontline plc (0000913290) (Filer)
Frontline Ltd. ("Frontline" or the "Company") (NYSE:FRO) announces that a Special General Meeting of Shareholders was held on December 20, 2022, at 8:00 a.m. local time, at Par-la-Ville Place, 4(th) Floor, 14 Par-la-Ville Road, Hamilton, Bermuda. The proposals set out below were all approved by Frontline's shareholders at the Special General Meeting: * * * Increase of Authorized Share Capital To approve an increase of Frontline's authorized share capital from $500,000,000 (divided into 500,000,000 ordinary shares, par value $1.00), to $600,000,000 (divided into 600,000,000 ordinary shares, par value $1.00), by the creation of an additional 100,000,000 ordinary shares, par value $1.00, w